Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: Report

AstraZeneca Enhertu granted priority review in US for metastatic HER2-positive solid tumours

Ruchika Sharma31 Jan 2024 12:45 PM IST

Cambridge: AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been...

Dr Reddys Labs API Mirfield facility gets 7 USFDA observations

Dr Reddy's Labs posts 11 percent increase in Q3 profit at Rs 1379 crore

Ruchika Sharma31 Jan 2024 11:50 AM IST

Revenues in the domestic market saw a rise of 5 per cent year-on-year to Rs 1,180 crore in the October-December period of this fiscal.

GSK Omjjara gets European Commission marketing authorisation

Ruchika Sharma29 Jan 2024 4:45 PM IST

London: GSK plc has announced the European Commission has granted marketing authorisation for Omjjara (momelotinib), a once-a-day, oral JAK1/JAK2...

Shilpa Medicare arm partners with Orion Corporation for Recombinant Human Albumin for European Market

Shilpa Medicare gets 2 observations from AGES, Austria for Unit 4 of Jadcherla facility

Ruchika Sharma29 Jan 2024 3:30 PM IST

Karnataka: Shilpa Medicare has received two minor observations from AGES, Austria at the conclusion of a Europe GMP inspection at the...

Cipla Samina Hamied to step down as Executive Vice Chairperson

Ruchika Sharma29 Jan 2024 1:30 PM IST

Mumbai: Drug major Cipla has said Samina Hamied has decided to step down from the position of Executive Vice Chairperson of the company, while...

Bayer Gadoquatrane new drug application accepted for review by USFDA

Bayer ordered to pay USD 2.25 billion in latest Roundup trial

Ruchika Sharma29 Jan 2024 12:30 PM IST

Bayer was ordered on Friday to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller,...

Haleon recalls some lots of adult cough syrup Robitussin over microbial contamination

Ruchika Sharma29 Jan 2024 10:00 AM IST

Haleon is recalling some lots of its adult cough syrup Robitussin because of microbial contamination, the U.S. Food and Drug Administration (FDA) has...

Maharashtra Boosts Support for Leprosy Hospitals Amid Rising Cases

Centre to introduce three drug treatment regime to stop leprosy transmission by 2027

Ruchika Sharma28 Jan 2024 5:00 PM IST

New Delhi: The Union Health Ministry has decided to implement a new treatment regimen for leprosy aimed at stopping its transmission at the...

Johna Norton to retire as Eli Lilly Executive Vice President of Global Quality

Ruchika Sharma28 Jan 2024 4:00 PM IST

Indianapolis: Eli Lilly and Company has announced that Johna Norton, executive vice president of Global Quality, will be retiring after...

Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapy

Sanofi Dupixent approved by USFDA for pediatric patients aged 1 to 11 years with eosinophilic esophagitis

Ruchika Sharma28 Jan 2024 2:30 PM IST

Paris: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of...

DPIIT collaborate with Pfizer to strengthen India healthcare innovation ecosystem

Laurus Labs, Krka to establish JV company in Hyderabad

Ruchika Sharma28 Jan 2024 11:30 AM IST

It is expected that the necessary procedures and documentation for the registration of the new joint venture company will be finalised by the end of...

EMA validates Type II variation application for Padcev with Keytruda for first line treatment of advanced Bladder Cancer: Pfizer

Ruchika Sharma28 Jan 2024 10:00 AM IST

Tokyo: Astellas Pharma Inc. and Pfizer Inc. have announced that the European Medicines Agency (EMA) has validated for review a Type II...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok